Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)

Masato Kataoka; Mitsuro Kanda; Kiyoshi Ishigure; Hiroshi Matsuoka; Yusuke Sato; Takao Takahashi; Chihiro Tanaka; Tomohiro Deguchi; Yoshihisa Shibata; Mikinori Sato; Hitoshi Inagaki; Takanori Matsui; Akinobu Kondo; Nao Takano; Haruyoshi Tanaka; Junichi Sakamoto; Koji Oba; Ken Kondo

doi:10.1245/s10434-016-5593-5

Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)

Masato Kataoka, Mitsuro Kanda, Kiyoshi Ishigure, Hiroshi Matsuoka, Yusuke Sato, Takao Takahashi, Chihiro Tanaka, Tomohiro Deguchi, Yoshihisa Shibata, Mikinori Sato, Hitoshi Inagaki, Takanori Matsui, Akinobu Kondo, Nao Takano, Haruyoshi Tanaka, Junichi Sakamoto, Koji Oba, Ken Kondo

Gastrointestinal Surgery

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Akinobu Kondo’s first name is incorrect in the original article. It is corrected as shown in this erratum. Also, the following Acknowledgment was inadvertently omitted: Acknowledgment This study was supported, in part, by the nonprofit organization Epidemiological and Clinical Research Information Network (ECRIN).

Original language	English
Pages (from-to)	1064
Number of pages	1
Journal	Annals of Surgical Oncology
Volume	23
DOIs	https://doi.org/10.1245/s10434-016-5593-5
Publication status	Published - 01-12-2016

All Science Journal Classification (ASJC) codes

Surgery
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1245/s10434-016-5593-5

Fingerprint

Dive into the research topics of 'Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)'. Together they form a unique fingerprint.

Cite this

Kataoka, M., Kanda, M., Ishigure, K., Matsuoka, H., Sato, Y., Takahashi, T., Tanaka, C., Deguchi, T., Shibata, Y., Sato, M., Inagaki, H., Matsui, T., Kondo, A., Takano, N., Tanaka, H., Sakamoto, J., Oba, K., & Kondo, K. (2016). Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9). Annals of Surgical Oncology, 23, 1064. https://doi.org/10.1245/s10434-016-5593-5

Kataoka, Masato ; Kanda, Mitsuro ; Ishigure, Kiyoshi et al. / Erratum to : The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9). In: Annals of Surgical Oncology. 2016 ; Vol. 23. pp. 1064.

@article{3111ce8d73ec491b8efb7cf4be28804d,

title = "Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)",

abstract = "Akinobu Kondo{\textquoteright}s first name is incorrect in the original article. It is corrected as shown in this erratum. Also, the following Acknowledgment was inadvertently omitted: Acknowledgment This study was supported, in part, by the nonprofit organization Epidemiological and Clinical Research Information Network (ECRIN).",

author = "Masato Kataoka and Mitsuro Kanda and Kiyoshi Ishigure and Hiroshi Matsuoka and Yusuke Sato and Takao Takahashi and Chihiro Tanaka and Tomohiro Deguchi and Yoshihisa Shibata and Mikinori Sato and Hitoshi Inagaki and Takanori Matsui and Akinobu Kondo and Nao Takano and Haruyoshi Tanaka and Junichi Sakamoto and Koji Oba and Ken Kondo",

note = "Publisher Copyright: {\textcopyright} 2016, Society of Surgical Oncology.",

year = "2016",

month = dec,

day = "1",

doi = "10.1245/s10434-016-5593-5",

language = "English",

volume = "23",

pages = "1064",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer New York",

}

Kataoka, M, Kanda, M, Ishigure, K, Matsuoka, H, Sato, Y, Takahashi, T, Tanaka, C, Deguchi, T, Shibata, Y, Sato, M, Inagaki, H, Matsui, T, Kondo, A, Takano, N, Tanaka, H, Sakamoto, J, Oba, K & Kondo, K 2016, 'Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)', Annals of Surgical Oncology, vol. 23, pp. 1064. https://doi.org/10.1245/s10434-016-5593-5

Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9). / Kataoka, Masato; Kanda, Mitsuro; Ishigure, Kiyoshi et al.
In: Annals of Surgical Oncology, Vol. 23, 01.12.2016, p. 1064.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum to

T2 - The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)

AU - Kataoka, Masato

AU - Kanda, Mitsuro

AU - Ishigure, Kiyoshi

AU - Matsuoka, Hiroshi

AU - Sato, Yusuke

AU - Takahashi, Takao

AU - Tanaka, Chihiro

AU - Deguchi, Tomohiro

AU - Shibata, Yoshihisa

AU - Sato, Mikinori

AU - Inagaki, Hitoshi

AU - Matsui, Takanori

AU - Kondo, Akinobu

AU - Takano, Nao

AU - Tanaka, Haruyoshi

AU - Sakamoto, Junichi

AU - Oba, Koji

AU - Kondo, Ken

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Akinobu Kondo’s first name is incorrect in the original article. It is corrected as shown in this erratum. Also, the following Acknowledgment was inadvertently omitted: Acknowledgment This study was supported, in part, by the nonprofit organization Epidemiological and Clinical Research Information Network (ECRIN).

AB - Akinobu Kondo’s first name is incorrect in the original article. It is corrected as shown in this erratum. Also, the following Acknowledgment was inadvertently omitted: Acknowledgment This study was supported, in part, by the nonprofit organization Epidemiological and Clinical Research Information Network (ECRIN).

UR - http://www.scopus.com/inward/record.url?scp=84988349778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988349778&partnerID=8YFLogxK

U2 - 10.1245/s10434-016-5593-5

DO - 10.1245/s10434-016-5593-5

M3 - Comment/debate

AN - SCOPUS:84988349778

SN - 1068-9265

VL - 23

SP - 1064

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

ER -

Kataoka M, Kanda M, Ishigure K, Matsuoka H, Sato Y, Takahashi T et al. Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9). Annals of Surgical Oncology. 2016 Dec 1;23:1064. doi: 10.1245/s10434-016-5593-5

Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer (Ann Surg Oncol, 10.1245/S10434-016-5557-9)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this